The pSFV1 eukaryotic expression vector is a new DNA expression system based on the Semliki Forest Virus (SFV) replicon, which has a wide host range and high level of expression efficiency. The SFV expression system has several advantages over other protein expression systems, including direct cloning into vectors and proper glycosylation of recombinant proteins. The SFV expression system is easy to use. The DNA of interest is cloned into the pSFV1 plasmid vector to serve as a template for in vitro synthesis of recombinant RNA, and the RNA is then transfected into tissue culture cells using a transfection reagent or by electroporation. Recombinant RNA in the cell drives its own replication and capping, resulting in the production of large amounts of heterologous proteins while inhibiting host protein synthesis. By transfecting pSFV1 in vitro-transcribed RNA into CHO-K1 and BHK-21 cells, high transfection efficiency and heterologous protein expression were achieved.
Among the proteins encoded by hepatitis C virus (HCV), the highly conserved core protein is thought to be involved in the immunomodulatory properties of the hepatitis virus. Recombinant viral vectors that express the HCV core protein and allow its transduction and thus expression of the protein into dendritic cells (DCs) may be useful tools for analyzing core protein properties. Vaccinia viruses and retroviruses have been used to transduce human DCs. Likewise, the use of Semliki Forest Virus to transfer genes into DCs has also been reported. This study aims to use SFV vector to express HCV Core protein in DCs derived from human monocytes, in which the subgenomic RNA encoding the structural protein is replaced by the HCV Core sequence, and then analyze the effect of its expression on DC function. This study demonstrates the use of rSFV to transduce human monocyte-derived DCs. However, even at an MOI of 20, no expression of HCV Core protein was detected. On the other hand, transduction induces activation of DCs, leading to IFN-induced upregulation of MxA protein, which is involved in blocking SFV replication but reducing heterologous protein expression.
In order to express the HCV core protein into human monocyte-derived DCs using recombinant SFV and thus evaluate the impact of this protein on DC function, the genomic region encoding HCV Core protein (aa 1-191) was cloned into SFV plasmid vector pSFV1 under the control of the subgenomic SFV promoter. The researchers first examined HCV Core protein expression after transfection of pSFV1-Core-derived in vitro-transcribed RNA into BHK-21 cells. Forty-eight hours after transfection, cells were tested for Core expression by indirect immunofluorescence using anti-HCV Core mAb B12.F8. Subsequently, HCV core protein expression of recombinant SFV particles was studied in BHK-21 cells. Figure 1b shows immunostaining analysis of infected cells with anti-HCV Core mAb B12.F8 48 hours after transduction. Additionally, cells were harvested at 12, 24, 36, 48, and 72 hours post-infection. The expression of HCV core protein at each time point was analyzed by Western blotting.
Figure 1. Indirect immunofluorescence method was used to detect hepatitis C virus core protein in BHK-21 cells. (a) BHK-21 cells transfected with pSFV1-Core-derived in vitro transcribed RNA, (b) BHK-21 cells infected with rSFV1-Core recombinant particles at MOI 0.1, and (c) BHK-21 control cells. (Navas, Maria-Cristina, et al., 2019)
The pSFV1 vector has several applications in molecular biology and gene expression studies. Here are some of its uses:
Gene expression: pSFV1 vector can be used to express genes of interest in a wide range of host cells. It allows high-level expression of the target gene due to the strong promoter present in the vector.
Viral protein production: The pSFV1 vector can also be used for the production of viral proteins. By introducing the gene encoding the viral protein into the vector, it can be transfected into host cells to produce large quantities of the desired protein, which can then be purified and used for various research purposes.
Vaccine development: The pSFV1 vector can be utilized for vaccine development against various viral diseases. By inserting the gene encoding the antigen into the vector, it can be used to generate viral-like particles that mimic the virus but are non-infectious. These particles can be used as vaccines to elicit an immune response against the target pathogen.
Functional studies: The pSFV1 vector can be employed for functional studies of genes or proteins. By overexpressing or knocking down specific genes or proteins in cells, researchers can investigate their role in various biological processes or disease pathways.
Overall, the pSFV1 vector offers a versatile platform for gene expression studies, viral protein production, vaccine development, functional studies, and gene therapy applications.
Customer Q&As
What type of vectors are pSFV1?
A: pSFV1 is a mammalian expression vector.
Which strain(s) can pSFV1 grow in?
A: pSFV1 can grow in Stbl3 strain.
Ask a Question
Customer Reviews
Reliable result
By using the pSFV1 vector, we can explore new avenues in their molecular biology research and potentially gain new insights into gene regulation and protein function.
United Kingdom
11/16/2021
Worked very well
The pSFV1 vector can achieve high-level expression of the gene of interest.
Write a Review